SCI Abstract

search
+
Second primary non-breast cancers in young breast cancer survivors
Second primary non-breast cancers in young breast cancer survivors
We evaluated the incidence, timing, and risk factors for second primary non-breast cancers (SPNBC) among young breast canc...
Incidence of local breast cancer recurrence with delayed radiation therapy
Incidence of local breast cancer recurrence with delayed radiation therapy
The purpose of this research was to examine the probability of ipsilateral breast cancer recurrence in individuals whose R...
Choosing breast-conserving therapy or mastectomy and subpectoral implant breast reconstruction: implications for pectoralis major function
Choosing breast-conserving therapy or mastectomy and subpectoral implant breast reconstruction: implications for pectoralis major function
An increasing number of women are choosing mastectomy and subpectoral implant (SI) breast reconstruction over breast-conse...
De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion—not further characterized
De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion—not further characterized
Surgical excision is often performed to exclude phyllodes tumor (PT) when Core Needle Biopsy (CNB) of the breast returns f...
Tamoxifen modulates nutrition deprivation-induced ER stress through AMPK-mediated ER-phagy in breast cancer cells
Tamoxifen modulates nutrition deprivation-induced ER stress through AMPK-mediated ER-phagy in breast cancer cells
Rapid proliferation and nutrition starvation in the tumor microenvironment pose significant challenges to cellular protein...
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, whi...
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Triple negative breast cancer (TNBC) is a challenging subtype characterized by the absence of estrogen receptor (ER), prog...
Surgical marker navigation system in breast conserving surgery and excision of non-palpable lesions: first Spanish single-center experience
Surgical marker navigation system in breast conserving surgery and excision of non-palpable lesions: first Spanish single-center experience
Due to the establishment of screening mammography for breast cancer detection, the number of non-palpable lesions has incr...
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer
While 18F-FDG PET/CT (FDG-PET/CT) is consensual for clinical stage ≥ IIB breast cancers (BC), its benefi...
Barrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysis
Barrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysis
Barrier films or dressings were reported to be effective in preventing radiation dermatitis (RD) in breast cancer patients...
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
The treatment landscape for HR(+)HER2(−) metastatic breast cancer (MBC) is evolving for patients with ESR1 mutations...
Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study
Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study
The potential value of detecting epithelial–mesenchymal transition (EMT) CTCs in early breast cancer, especially dur...
Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases
Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases
To define the spectrum of germline pathogenic variants (PVs) and copy number variant (CNV) in cancer susceptibility genes ...
Characterization of time toxicity in older patients with metastatic breast cancer
Characterization of time toxicity in older patients with metastatic breast cancer
Recognizing that receiving healthcare can be time intensive and burdensome, time toxicity has been conceptualized as the t...
Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations
Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations
The NCCN guidelines recommend genetic testing in those patients at increased risk of breast cancer in order to identify ca...
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes
The prognostic utility and biological correlates of neutrophil to lymphocyte ratio (NLR), a potential biomarker of the bal...
Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)
Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)
This paper is a narrative review of a major clinical challenge at the heart of breast cancer care: determining which patie...
Primary MALT lymphoma of the breast: pathological and radiological characteristics
Primary MALT lymphoma of the breast: pathological and radiological characteristics
Primary Mucosa-associated lymphoid tissue (MALT) lymphoma is a rare diagnosis in the breast, and clinical diagnosis based ...
Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration
Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration
Hotspot estrogen receptor alpha (ER/ESR1) mutations are recognized as the driver for both endocrine resistance and metasta...
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study
This study focused on identifying a hereditary predisposition in women previously diagnosed with early-onset breast cancer...
Development of a core outcome set for breast cancer-related lymphedema: a Delphi study
Development of a core outcome set for breast cancer-related lymphedema: a Delphi study
For breast cancer survivors (BCS) living with breast cancer-related lymphedema (BCRL), what outcome domains (OD) should be...
Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer
Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer
Depression is among the most common comorbid psychiatric disorders of patients with breast cancer. Depression decreases pa...
Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study
Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study
To analyze concordance rates between individual foci of bifocal BC for histological grade, type and intrinsic subtype base...
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
The Clinical Treatment Score post-5 years (CTS5) is an easy-to-use tool estimating the late distant recurrence (L...
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study
Endocrine therapy (ET) in combination with CDK 4/6 inhibitors (CDK 4/6i) is the standard treatment modality for hormone re...
Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk
Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk
Follow-up guidelines barely diverge from a one-size-fits-all approach, even though the risk of recurrence differs per pati...
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study
Digistain Index (DI), measured using an inexpensive mid-infrared spectrometer, reflects the level of aneuploidy in unstain...
Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies
Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies
Recruit and sequence breast cancer subjects in Guatemalan and US Hispanic populations. Identify optimum strategies to recr...
Survival among patients with untreated metastatic breast cancer: “What if I do nothing?”
Survival among patients with untreated metastatic breast cancer: “What if I do nothing?”
We sought to assess survival outcomes of patients with de novo metastatic breast cancer (dnMBC) who did not receive treatm...
Development of a core set of outcome measures to be applied toward breast cancer-related lymphedema core outcome domains
Development of a core set of outcome measures to be applied toward breast cancer-related lymphedema core outcome domains
For breast cancer survivors (BCS) living with breast cancer-related lymphedema (BCRL), what outcome measures (OMs) are rec...
Load More
format_indent_increase